The return to profitability removes immediate distress risk, but the dilutive rights offering and backstop structure—with Oaktree and insiders able to take junior preferred stock with warrants—creates significant overhang for common equity. Watch for the final Q3 2026 10-Q filing for GAAP vs. adjusted net income reconciliation and the outcome of the November 12, 2026 rights offering expiration to gauge dilution magnitude.
Price Chart
Executive Summary
UWM Holdings announced preliminary Q3 2026 results with net income of $205-$220M, a sharp reversal from the $451.9M net loss in Q2 2026, alongside a $400M rights offering that the company admits is unlikely to attract material outside subscription. The filing combines an operational recovery with a dilutive capital raise that will likely be backstopped by insiders and Oaktree, adding significant preferred stock and warrant overhang.
Key Financial Metrics
Key Facts
- Preliminary Q3 2026 net income of $205-$220M, a major improvement from the $451.9M net loss in Q2 2026 and the $247.0M loss in Q1 2025.
- Total revenue of $800-$825M, down from $888.0M in Q2 2026 and $901.4M in Q1 2026, driven by lower origination volume.
- Loan origination volume fell to $33.4B from $44.9B in Q1 2026, with purchase originations of $22.8B and refinance originations of $10.6B.
- Gain margin improved to ~124 bps from 123 bps in Q1 2026.
- MSR portfolio UPB grew to ~$270B with a WAC of ~5.97%.
- Full-year 2026 revenue guidance lowered to $3.35-$3.50B, below prior expectations, due to lower industry origination volume.
- Company expects to sell $70-$80B of MSRs in Q4 2026 with proceeds exceeding $1.8B to pay down non-funding debt.
- A $400M rights offering commenced October 5, 2026; the company states material outside subscription is unlikely based on current share price.
- The rights offering is backstopped by Oaktree (option) and SFS Group/Mat Ishbia (obligation), with backstop parties able to take junior perpetual preferred stock with warrants equal to 20% of the liquidation preference.
- Total Preferred and Common Equity was ~$2.8B at September 30, 2026, including $1.5B in redeemable preferred stock from the August 2026 Oaktree/SFS investment.
Financial Impact
Net income swing of ~$657-$672M from Q2 2026 loss to Q3 2026 profit; $400M dilutive rights offering with additional preferred/warrant overhang from backstop; $1.8B+ in planned MSR sales to reduce leverage.
Risk Factors
- Rights offering likely to be fully backstopped by insiders and Oaktree, resulting in substantial dilution and/or preferred stock overhang for common shareholders.
- Full-year revenue guidance lowered due to declining industry origination volume, signaling continued headwinds in the mortgage market.
- Preliminary results are unaudited and subject to material change upon completion of financial close procedures.
- Planned $70-$80B MSR sale in Q4 2026, while deleveraging, reduces future servicing income and may impact earnings power.
- Non-funding debt to equity ratio remains elevated at 1.75x-1.80x despite the preferred equity injection.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001783398-26-000128 |
| Document: q32026ex-991prelimpressrel.htm | 0001783398-26-000128 |
| Document: uwm_3q26xfinalexhibit.htm | 0001783398-26-000128 |
| Document: 0001783398-26-000128-index-headers.html | 0001783398-26-000128 |
| Document: 0001783398-26-000128-index.html | 0001783398-26-000128 |
| Document: 0001783398-26-000128.txt | 0001783398-26-000128 |
| 8-K Data (Synthetic) | 0001783398-26-000128 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | 8-K | $1.18 | awaiting T+1 | — | $1.45 (+22.88%) |
Oct 5, 2026 20d ago | 8-K | $1.20 $1.13 | ▲ +5.83% | ▲ +5.59% | $1.45 (−20.83%) |
Oct 1, 2026 24d ago | 8-K | $1.26 $1.29 | ▲ +2.38% | ▲ +1.71% | $1.45 (+15.08%) |
Sep 29, 2026 26d ago | SC 13G | $1.24 $1.18 | ▼ −4.84% | ▼ −4.63% | $1.45 (+16.94%) |
Aug 9, 2026 11w ago | Institutional Cluster | $1.41 $1.53 | ▲ +8.51% | ▲ +8.83% | $1.45 (+2.84%) |
Aug 5, 2026 11w ago | S-3ASR | $1.84 $1.20 | ▼ −34.78% | ▼ −34.62% | $1.45 (−21.20%) |
Jun 15, 2026 18w ago | DFAN14A | $2.35 $2.43 | ▲ +3.40% | ▲ +4.00% | $1.45 (−38.30%) |
Jun 11, 2026 19w ago | Institutional Cluster | $2.39 $2.38 | ▼ −0.42% | ▼ −0.96% | $1.45 (−39.33%) |
Jun 11, 2026 19w ago | Institutional Cluster | $2.39 $2.38 | ▼ −0.42% | ▼ −0.96% | $1.45 (−39.33%) |
May 28, 2026 21w ago | DFAN14A | $3.14 $3.06 | ▼ −2.55% | ▼ −2.79% | $1.45 (−53.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers